Health Care & Life Sciences » Biotechnology | Anterogen Co. Ltd.

Anterogen Co. Ltd.

Anterogen Co. Ltd.
Stock Exchange Korea Exchange
EPS
 KRW147
Market Cap
 KRW753.21 B
Shares Outstanding
 7.95 M
Public Float
 4.78 M

Profile

Address
Unit 405, Namsung Plaza
Seoul SL 08589
Korea, Republic Of
Employees -
Website http://www.anterogen.com
Updated 09/14/2018
Anterogen Co., Ltd. develops stem cell therapy treatments. Its products include Cupistem and Remodullin injection, Queencell and stem cell conditioned media. In addition, It also offers stem cell banking and analysis services.

Financials

View All
Created with Highcharts 5.0.14Anterogen Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.1 8101 8101 4161 4165858372372739739201320142015201620170500100015002000
Created with Highcharts 5.0.14Anterogen Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.9169161 8341 8343 5323 5324 8964 8965 3575 3572013201420152016201701k2k3k4k5k6k

Bang-Hee Han
Senior Managing Director & Head-Clinic
Mi-Hyung Kim
Senior Managing Director & Head-Research Institute
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.